NRT Share Price

Open 0.05 Change Price %
High 0.05 1 Day 0.00 0.00
Low 0.05 1 Week 0.00 0.00
Close 0.05 1 Month -0.02 -28.57
Volume 1093422 1 Year -0.07 -58.33
52 Week High 0.12
52 Week Low 0.05
NRT Important Levels
Resistance 2 0.05
Resistance 1 0.05
Pivot 0.05
Support 1 0.05
Support 2 0.05
ASX Australia Most Active Stocks
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
FMG 5.31 1.92%
FMG 5.31 1.92%
TLS 4.22 0.00%
TLS 4.22 0.00%
TLS 4.22 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
PGS 0.02 100.00%
PGS 0.02 100.00%
PGS 0.02 100.00%
PGS 0.02 100.00%
LML 0.05 66.67%
LML 0.05 66.67%
ETE 0.03 50.00%
ETE 0.03 50.00%
BNV 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
GBP 0.02 -33.33%
GBP 0.02 -33.33%
GRV 0.03 -25.00%
GRV 0.03 -25.00%
More..

Novogen Ltd (ASX: NRT)

NRT Technical Analysis 5
As on 28th Apr 2017 NRT Share Price closed @ 0.05 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.09 & Strong Sell for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
NRT Target for April
1st Target up-side 0.08
2nd Target up-side 0.09
3rd Target up-side 0.1
1st Target down-side 0.06
2nd Target down-side 0.05
3rd Target down-side 0.04
NRT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.novogen.com
NRT Address
NRT
16 - 20 Edgeworth David Avenue
Level 1
Hornsby, NSW 2077
Australia
Phone: 61 2 9476 0344
Fax: 61 2 9476 0388
NRT Latest News
Can This Stock Gain Any Traction: Novogen Limited (NASDAQ:NVGN)?   Morgan Research   - 28th Apr 17
Novogen Limited (NVGN) Earns Daily News Sentiment Rating of -0.12   BBNS   - 27th Apr 17
Novogen Limited (NVGN) Earning Somewhat Negative Media Coverage, Study Shows   The Cerbat Gem   - 21st Apr 17
Form 6-K NOVOGEN LTD For: Jan 10   StreetInsider.com   - 10th Jan 17
Novogen Submits Investigational New Drug (IND) Application to the US FDA For ...   PR Newswire (press release)   - 11th Aug 16
Novogen Patent Covering Anisina(TM) Has Proceeded to Grant   PR Newswire (press release)   - 14th Jun 16
Novogen Provides Update On Development Of Cantrixil   PR Newswire (press release)   - 02nd May 16
Novogen Limited sinks 30%: Here's why   Motley Fool Australia   - 21st Apr 15
Novogen Announces Breakthrough Discovery in the Treatment of Melanoma   PR Newswire (press release)   - 16th Dec 14
Novogen Receives Funding Support To Commence Studies In Muscular Dystrophy   PR Newswire (press release)   - 12th Aug 14
Interactive Technical Analysis Chart Novogen Ltd ( NRT ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Novogen Ltd
NRT Business Profile
Novogen Limited operates as a pharmaceutical drug development company worldwide. It focuses on the development of a family of anti-cancer drugs based on super-benzopyran and stealth drug technologies. The company’s lead drug candidate is CS-6, a mitochondrial electron transfer inhibitor for the treatment of temozolomide-resistant glioblastoma multiforme and late-stage chemo-refractory ovarian cancer. Novogen Limited was founded in 1994 and is based in Hornsby, Australia.